Opening Plenary

9am Chair Introduction

Chad Salisbury, Senior Vice President, Project Farma

9.05am Presentation Title: Top 10 Events of 2023 for Cell and Gene Therapies

Susan Nicholas, Chief Executive Officer, Propel Biosciences

9.15am Cryport Fireside Chat

Between Chad Salisbury, Senior Vice President, Project Farma and Jerrell W. Shelton, President and Chief Executive Officer, Cryoport Inc

9:25am "Special Announcement"

9:35am Fireside Chat: Women in Advanced Therapies: The Power of Collaboration & Community at Scale

Moderated By: Becky-Johnson Kent, Director of Commercial Partnerships & Head of Women in Advanced Therapies, Phacilitate

Lynn Fischer, Founder and Board Member, Title 21

9:50am Presentation Title: Regulatory Updates for Cell and Gene Therapy

Celia Witten, Deputy Director, CBER, FDA

10.05am Closing Panel: Cell and Gene Therapy in 2024 and Beyond: What do the Next Five Years Hold for CGT?

Joined by:

Lore Gruenbaum, Vice President, Therapy Acceleration Program, The Leukemia & Lymphoma Society

Warner Biddle, Global Head of Commercial, Kite, a Gilead Company

Celia Witten, Deputy Director, CBER, FDA